Therapeutic targets and medicaments involving p230/golgin-245

Details for Australian Patent Application No. 2008329561 (hide)

Owner The University of Melbourne The University of Queensland

Inventors Hammond, Luke Alexander; Lock, John George; Gleeson, Paul Antony; Stow, Jennifer Lea; Lieu, Zi Zhao

Agent Davies Collison Cave

Pub. Number AU-A-2008329561

PCT Pub. Number WO2009/067755

Priority 2007906558 30.11.07 AU

Filing date 28 November 2008

Wipo publication date 4 June 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

17 June 2010 PCT application entered the National Phase

  PCT publication WO2009/067755 Priority application(s): WO2009/067755

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008329562-Methods of inducing pluripotency involving Sox2 protein

2008329559-Liquid treatment apparatus